Monsanto Press Release

Monsanto's Position On Gene Protection (Terminator) Technology

A patent issued to Delta & Pine Land Co. and USDA describes a new, theoretical technique that was designed to control the germination of seeds produced by plants modified by biotechnology. The original research by USDA was initiated to aid in prevention of gene flow or to eliminate the possibility of outcrossing. The securing of a patent -- generally an initial step in research and development -- does not predict commercial viability and acceptability. The procedure has not yet been tested and it may be five to seven years before it is actually fully developed enough to be commercialised.

One important issue, especially in developing countries, is that of small farmholders who rely on saved seed to provide growing stocks for the next year. These farmers and others have expressed concerns about the use of gene protection technologies. We believe the concerns about these types of technologies should be heard and carefully considered prior to any commercialisation decision. We support and have called for a thorough, independent and comprehensive consideration and public discussion about gene protection technologies. Until such an examination has been conducted, Monsanto will not attempt to comercialise such gene protection technologies.